For comparison, Pfizer reported yesterday that Abrysvo made full-year sales of $890 million, which - while respectable - were well below its competitor. However, it brought in $515 million in the ...

mResvia’s top-line score comes in slightly lower than Arexvy and slightly above Abrysvo, they note – notwithstanding differences in study design – and will be weighed up against the ...

The FDA has approved three vaccines to prevent RSV in adults who are 60 and older: Moderna’s mRESVIA, approved in June 2024, and GSK’s Arexvy and Pfizer’s Abrysvo, both approved in May 2023. The ...

The architect Frida Escobedo has drawn on her Mexican heritage in reimagining the galleries for Modern and contemporary art. By Robin Pogrebin The art collective behind teamLab, which started in ...

Nirsevimab is recommended for all infants younger than 8 months whose mothers did not receive the maternal RSV vaccine (Abrysvo; Pfizer) during pregnancy. It should be administered shortly before ...

(NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF ...

Dan Orlovsky: Josh Allen's next 10 weeks are 'legacy-defining' Dan Orlovsky explains why Josh Allen's next 10 weeks are crucial as the Bills try to make a Super Bowl run.

Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages ...